World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
34853
World Ranking
17362
National Ranking
264

Overview

Andreas Jung is affiliated with the University of Zurich in Switzerland, where their research focuses primarily on the field of Medicine with a concentration in Oncology. Their scholarly work covers significant subfields including Pulmonary and Respiratory Medicine, Cancer Research, Hepatology, and Pathology and Forensic Medicine.

The scientist has contributed extensively to topics related to colorectal cancer treatments and studies, cancer genomics and diagnostics, lung cancer treatments and mutations, hepatocellular carcinoma treatment and prognosis, genetic factors in colorectal cancer, gastric cancer management and outcomes, as well as pancreatic and hepatic oncology research.

Jung has authored and co-authored numerous papers, with recent publications including:

  • FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial (2020), published in British Journal of Cancer
  • Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study (2020), Journal of Thoracic Oncology
  • Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM) (2022), Annals of Oncology
  • Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board (2022), Journal of Cancer Research and Clinical Oncology
  • Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer (2021), Cellular and Molecular Gastroenterology and Hepatology

Their collaborative work extends alongside frequent co-authors including Volker Heinemann, Thomas Kirchner, Sebastian Stintzing, Jörg Kumbrink, and Dominik Paul Modest.

Andreas Jung's research articles are regularly published in several notable scientific venues, among which are:

  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Journal of Cancer Research and Clinical Oncology
  • British Journal of Cancer
  • Journal of Thoracic Oncology

Best Publications

  • Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

    Hiroki Kato;Osamu Takeuchi;Shintaro Sato;Mitsutoshi Yoneyama

  • 5'-Triphosphate RNA Is the Ligand for RIG-I

    Veit Hornung;Jana Ellegast;Sarah Kim;Krzysztof Brzózka

  • FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

    Volker Heinemann;Ludwig Fischer von Weikersthal;Thomas Decker;Alexander Kiani

  • Migrating cancer stem cells — an integrated concept of malignant tumour progression

    Thomas Brabletz;Andreas Jung;Simone Spaderna;Falk Hlubek

  • Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

    Thomas Brabletz;Andreas Jung;Simone Reu;Marc Porzner

  • Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

    Marco Tartaglia;Charlotte M Niemeyer;Alessandra Fragale;Alessandra Fragale;Xiaoling Song

  • β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer

    Thomas Brabletz;Andreas Jung;Serpil Dag;Falk Hlubek

  • Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin

    Thomas Brabletz;Falk Hlubek;Simone Spaderna;Otto Schmalhofer

  • The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer

    Simone Spaderna;Otto Schmalhofer;Mandy Wahlbuhl;Arno Dimmler

  • High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer

    Johan Forssell;Åke Öberg;Maria L. Henriksson;Roger Stenling

  • A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

    Simone Spaderna;Otto Schmalhofer;Falk Hlubek;Geert Berx

  • Frequency and Type of KRAS Mutations in Routine Diagnostic Analysis of Metastatic Colorectal Cancer

    Jens Neumann;Evelyn Zeindl-Eberhart;Thomas Kirchner;Andreas Jung

  • Recombination: Multiply infected spleen cells in HIV patients.

    Andreas Jung;Reinhard Maier;Jean-Pierre Vartanian;Gennady Bocharov

  • Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

    Marcus Maurer;Sabine Altrichter;Thomas Bieber;Tilo Biedermann

  • FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.

    Sebastian Stintzing;Sebastian Stintzing;Dominik P Modest;Dominik P Modest;Lisa Rossius;Markus M Lerch

  • CD133 expression is an independent prognostic marker for low survival in colorectal cancer

    D. Horst;L. Kriegl;Jutta Engel;T. Kirchner

  • Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

    Thomas Jamieson;Mairi Clarke;Colin W. Steele;Michael S. Samuel

  • KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program

    J. H. J. M. van Krieken;A. Jung;T. Kirchner;F. Carneiro

  • Nuclear Overexpression of the Oncoprotein β-Catenin in Colorectal Cancer is Localized Predominantly at the Invasion Front

    Thomas Brabletz;Andreas Jung;Kathrin Hermann;Klaus Günther

  • Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.

    Volker Heinemann;Sebastian Stintzing;Thomas Kirchner;Stefan Boeck

Frequent Co-Authors

Volker Heinemann
Volker Heinemann Ludwig-Maximilians-Universität München
Thomas Brabletz
Thomas Brabletz University of Erlangen-Nuremberg
Werner Scheithauer
Werner Scheithauer Medical University of Vienna
Thomas Decker
Thomas Decker University of Vienna
Werner Hohenberger
Werner Hohenberger University of Erlangen-Nuremberg
Heiko Hermeking
Heiko Hermeking German Cancer Research Center
Helmut Blum
Helmut Blum Ludwig-Maximilians-Universität München
Jens T. Siveke
Jens T. Siveke German Cancer Research Center
Wilko Weichert
Wilko Weichert Technical University of Munich
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare programs can open diverse career opportunities beyond studying Medicine in the USA. For those seeking alternative paths into healthcare, several online degrees provide flexibility and solid entry points.

Nursing remains a popular option with flexible entry requirements. Many schools now offer an lpn program no entrance exam, allowing students to start their practical nursing journey without traditional test barriers.

Healthcare leadership roles are also on the rise. Earning a health administration degree online can prepare you for management and administrative roles, supporting patient care behind the scenes.

Nurses looking to advance their credentials may consider specialized bridge programs. If you have an associate degree in nursing, asn to np programs offer a direct pathway to becoming a nurse practitioner.

For those interested in preventative care and wellness, a nutrition degrees online can lead to rewarding careers in dietary planning or public health education, supporting individuals and communities in leading healthier lives.

Best Scientists Citing Andreas Jung

Trending Scientists

Recently Published Articles